Literature DB >> 9322627

In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines.

Y J Lidor1, W E Lee, J H Nilson, I H Maxwell, L J Su, E Brand, L M Glode.   

Abstract

OBJECTIVE: Our goal was to determine whether toxicity of the diphtheria toxin A-chain gene regulated by the human chorionic gonadotropin promoter can be directed to malignant ovarian cell lines. STUDY
DESIGN: Plasmids containing diphtheria toxin A-chain gene linked to the regulatory elements of the metalloergothioneine and human chorionic gonadotropin promoters were transfected into the cell lines. Expression of diphtheria toxin A-chain gene was determined by the inhibition of a cotransfected luciferase reporter gene.
RESULTS: Cytotoxicity of the diphtheria toxin A-chain gene is shown in a dose-responsive manner. Transfection of a plasmid expressing the diphtheria toxin A-chain gene controlled by a constitutive promoter readily inhibits protein synthesis. Specific inhibition of luciferase protein synthesis occurs in ovarian cancer cells transfected with the diphtheria toxin A-chain gene under the control of the human chorionic gonadotropin promoters when compared with normal ovarian epithelial cells or fibroblasts.
CONCLUSIONS: These data demonstrate the preferential expression of the diphtheria toxin A-chain gene, regulated by the human chorionic gonadotropin promoter, to ovarian cancer cell lines. This provides an avenue for targeting such cells for suicide, toxin, or cytokine genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9322627     DOI: 10.1016/s0002-9378(97)70149-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Suicidal gene therapy in an NF-κB-controlled tumor environment as monitored by a secreted blood reporter.

Authors:  C E Badr; J M Niers; D Morse; J A Koelen; P Vandertop; D Noske; T Wurdinger; P A Zalloua; B A Tannous
Journal:  Gene Ther       Date:  2010-12-09       Impact factor: 5.250

2.  Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells.

Authors:  Michael Bordonaro; Darina L Lazarova; Alan C Sartorelli
Journal:  Nucleic Acids Res       Date:  2004-05-11       Impact factor: 16.971

Review 3.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 4.  Targeted Diphtheria Toxin-Based Therapy: A Review Article.

Authors:  Fatemeh Shafiee; Marc G Aucoin; Ali Jahanian-Najafabadi
Journal:  Front Microbiol       Date:  2019-10-18       Impact factor: 5.640

Review 5.  Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents.

Authors:  Akmal M Asrorov; Bahtiyor Muhitdinov; Bin Tu; Sharafitdin Mirzaakhmedov; Huiyuan Wang; Yongzhuo Huang
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

Review 6.  Modular Cre/lox system and genetic therapeutics for colorectal cancer.

Authors:  Michael Bordonaro
Journal:  J Biomed Biotechnol       Date:  2009-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.